CountryAfghanistanAlbaniaAlgeriaAndorraAngolaAntigua & BarbudaArgentinaArmeniaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBhutanBoliviaBosnia & HerzegovinaBotswanaBrazilBruneiBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCentral African RepublicChadChileChinaColombiaComorosCongoCongo Democratic RepublicCosta RicaCote d'IvoireCroatiaCubaCyprusCzech RepublicDenmarkDjiboutiDominicaDominican RepublicEcuadorEast TimorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEthiopiaFijiFinlandFranceGabonGambiaGeorgiaGermanyGhanaGreeceGrenadaGuatemalaGuineaGuinea-BissauGuyanaHaitiHondurasHungaryIcelandIndiaIndonesiaIranIraqIrelandIsraelItalyJamaicaJapanJordanKazakhstanKenyaKiribatiKorea NorthKorea SouthKosovoKuwaitKyrgyzstanLaosLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacedoniaMadagascarMalawiMalaysiaMaldivesMaliMaltaMarshall IslandsMauritaniaMauritiusMexicoMicronesiaMoldovaMonacoMongoliaMontenegroMoroccoMozambiqueMyanmar (Burma)NamibiaNauruNepalThe NetherlandsNew ZealandNicaraguaNigerNigeriaNorwayOmanPakistanPalauPalestinian State*PanamaPapua New GuineaParaguayPeruThe PhilippinesPolandPortugalQatarRomaniaRussiaRwandaSt. Kitts & NevisSt. LuciaSt. Vincent & The GrenadinesSamoaSan MarinoSao Tome & PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth SudanSpainSri LankaSudanSurinameSwazilandSwedenSwitzerlandSyriaTaiwanTajikistanTanzaniaThailandTogoTongaTrinidad & TobagoTunisiaTurkeyTurkmenistanTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States of AmericaUruguayUzbekistanVanuatuVatican City (Holy See)VenezuelaVietnamYemenZambiaZimbabwe
Multi User License - $2,500
Biomaterials are synthetic or natural materials that are artificially generated and utilised to interact with biological systems for medical reasons and therapies. In medicinal applications, they are frequently employed to supplement or replace a natural function.
They are frequently biodegradable, and some are bio-absorbable, which means they are gradually expelled from the body after performing a role. Metals, ceramics, plastic, glass, and even living cells and tissue can all be utilised to create a biomaterial.
The biomaterial industry is expected to increase dramatically over the coming years as a result of advances in tissue engineering, regenerative medicine, and other fields.
Furthermore, considerable financing from government organisations for product innovation is opening up new opportunities for growth in the biomaterials industry.
The Europe Biomaterials Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2026, registering a CAGR of XX% from 2022 to 2027.
Evonik, a speciality chemical manufacturer, has expanded its biomaterials range with the addition of a new PEEK filament for 3D printed implants. VESTAKEEP iC4800 3DF is an osteoconductive PEEK filament that aids in bone and implant fusion.
The high-performance polymer may be processed using extrusion-based 3D printing technologies such as fused filament fabrication (FFF). At the AAOS trade expo, the new product will be revealed for the first time
The new PEEK filament for 3D printed implants is a biomaterial from Evonik’s VESTAKEEP Fusion product family, which was started recently.
The novel high-performance polymer has excellent biocompatibility and biostability, as well as increased osteoconductive characteristics.
To achieve osteoconductivity, biphasic calcium phosphate, a functional special ingredient, was employed (BCP). The BCP addition promotes bone cell adhesion to implants, which improves the bone-implant contact, commonly known as osteointegration. This will speed up bone fusion and thereby patient rehabilitation.
© Copyright 2017-2022. Mobility Foresights. All Rights Reserved.